Critical Pharmaceuticals Limited Announces Successful Completion of Second Clinical Trial on CP024 Intranasal Growth Hormone
2/12/2013 11:00:34 AM
More...
|
Critical Pharmaceuticals Limited and the University of Nottingham to Develop Nano-Enabled Nasal Spray for Osteoporosis
2/16/2012 9:07:17 AM
More...
|
Critical Pharmaceuticals Limited Announce Interim Results of CP024 Nasal hGH Phase 1 Program that Show Comparable Bioactivity to Injection
9/6/2011 11:28:34 AM
More...
|
PolyTherics and Critical Pharmaceuticals Limited Enter Drug Development Collaboration with Funding From the Technology Strategy Board
4/5/2011 8:53:23 AM
More...
|
Critical Pharmaceuticals Limited CriticalSorb(TM) Nasal Drug Delivery Technology Shows Excellent Local Tolerability in Long Term Preclinical Studies
3/8/2011 10:10:56 AM
More...
|
Critical Pharmaceuticals Limited Secures £1.5M from Wellcome Trust to Develop hGH Nasal Spray
10/14/2009 9:53:23 AM
More...
|
Global Health Ventures and Critical Pharmaceuticals Limited Sign Memorandum of Understanding for Anti-Obesity Drug
1/28/2009 10:45:25 AM
More...
|
Critical Pharmaceuticals Limited Raise GBP650K Investors Endorse CriticalMix Drug Delivery Technology and own Pipeline Potential
11/10/2008 9:10:08 AM
More...
|
Critical Pharmaceuticals Limited Enter Sustained Release hGH Arena Preclinical Results of New Somatropin Formulation Demonstrate Advantages Over Existing Once-Daily Product
10/1/2008 8:36:03 AM
More...
|
Freeths Puts Positive Spin On Critical Pharmaceuticals Limited
10/19/2005 5:12:45 PM
More...
|